Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Deferred Taxes (2016 - 2025)

Orthofix Medical's Deferred Taxes history spans 15 years, with the latest figure at -$110000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes rose 26.67% year-over-year to -$110000.0, compared with a TTM value of $223000.0 through Dec 2025, down 83.54%, and an annual FY2025 reading of $223000.0, down 83.54% over the prior year.
  • Deferred Taxes for Q4 2025 was -$110000.0 at Orthofix Medical, down from $321000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $22.3 million in Q4 2021, with the low at -$1.7 million in Q3 2021.
  • Average Deferred Taxes over 5 years is $1.3 million, with a median of $307000.0 recorded in 2022.
  • Year-over-year, Deferred Taxes surged 3225.48% in 2021 and then crashed 294.2% in 2023.
  • Tracing OFIX's Deferred Taxes over 5 years: stood at $22.3 million in 2021, then crashed by 98.68% to $293000.0 in 2022, then crashed by 294.2% to -$569000.0 in 2023, then soared by 73.64% to -$150000.0 in 2024, then grew by 26.67% to -$110000.0 in 2025.
  • Per Business Quant, the three most recent readings for OFIX's Deferred Taxes are -$110000.0 (Q4 2025), $321000.0 (Q3 2025), and -$433000.0 (Q2 2025).